PALEO
0756.986.614 · rovalta.com · 05/11/2026
PALEO
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPALEO is a Private limited company incorporated in 2020. Its main activity is: Wholesale of other food, including fish, crustaceans and molluscs. Its registered office is in Leuven. It employs on average 20,4 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0756.986.614
- Incorporation
- 26/10/2020
- Legal form
- Private limited company
- Registered office
- Gaston Geenslaan 1
3001 Leuven · FlandreSee on map - Contributed capital
- 7 625 258,07 €
- Latest accounts
- 31/12/2025
- Average workforce
- 20,4 ETP
Joint committees (1)
- 220
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 1,5 M € | +62.0% | 897,8 k € | +293% | -464,7 k € | -40.0% | -331,8 k € | -41.8% | -233,9 k € |
| EBITDA | -1,4 M € | -33.5% | -1 M € | +25.4% | -1,4 M € | -131% | -604,4 k € | -120% | -274,1 k € |
| Operating result | -5,3 M € | -25.3% | -4,2 M € | -154% | -1,7 M € | -153% | -656,8 k € | -139% | -275 k € |
| Net result | -5,2 M € | -35.0% | -3,8 M € | -144% | -1,6 M € | -136% | -664,7 k € | -140% | -276,6 k € |
| Balance sheet | |||||||||
| Equity | 2,5 M € | -67.8% | 7,6 M € | +40.0% | 5,4 M € | +437% | 1 M € | -17.5% | 1,2 M € |
| Total assets | 3,1 M € | -62.1% | 8,1 M € | +42.7% | 5,7 M € | +407% | 1,1 M € | -21.7% | 1,4 M € |
| Cash | 1,2 M € | +64.3% | 740,9 k € | +424% | 141,4 k € | -55.6% | 318,4 k € | -73.5% | 1,2 M € |
| Debts | 625 k € | +24.3% | 502,7 k € | +104% | 246,1 k € | +126% | 109,1 k € | -46.1% | 202,5 k € |
| Other | |||||||||
| Workforce | 20,4 ETP | -1.0% | 20,6 ETP | +79.1% | 11,5 ETP | +238% | 3,4 ETP | +240% | 1,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20256 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Luc Celis | Directorsince 03/04/2026 | ||
| Managing directorsince 15/02/2023Director27/10/2021 → 2021 accountsended | |||
Jan Christoph Gras | Directorsince 15/02/2023 | ||
| Director26/05/2023 → 28/01/2026 | |||
| Managing director15/02/2023 → 28/01/2026Director27/10/2021 → 2021 accountsended | |||
Philip Patrick Mertens | Director15/02/2023 → 28/01/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Luc Selis | Director27/10/2021 → 2021 accounts | ||
Andy de Jong | Directoruntil 27/10/2021 | ||
Hermes Sanctorum-Vandevoorde | Directoruntil 27/10/2021 |
Other companies at this address
Gaston Geenslaan 1 3001 Leuven| Company | CBE no. |
|---|---|
Bio-Incubator Leuven● Active | 0876.605.232 |
Community Building Arenberg● Active | 1014.096.594 |
Creative Biolabs Belgium● Active | 1028.942.544 |
DName-iT● Active | 0506.754.823 |
Fisherman● Active | 0804.287.079 |
Fishway● Active | 0787.869.632 |
Formac Pharmaceuticals● Active | 0892.914.395 |
IDA INTERNATIONAL● Active | 1002.119.470 |
Lever Bio Belgium● Active | 1039.455.958 |
Maatschap reMYND● Active | 1019.655.090 |
miDiagnostics● Active | 0641.984.602 |
Oxurion● Active | 0881.620.924 |
PARKEERGEBOUW● Active | 1009.039.728 |
Pledge Therapeutics● Active | 0726.743.301 |
Qmineral● Active | 0837.633.897 |
Raya Therapeutic● Active | 1003.128.171 |
ReGenesys● Active | 0877.070.337 |
ReGenesys EU● Active | 0544.577.301 |
reMYND● Active | 0476.910.101 |
ReWrite● Active | 1016.891.283 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 26/10/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 15 months |
| Filing date | 10/07/2026 | 23/06/2025 | 08/07/2024 | 01/06/2023 | 25/07/2022 |
| General meeting | 16/06/2026 | 17/06/2025 | 18/06/2024 | 26/05/2023 | 17/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 16/06/2026 | 10/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 17/06/2025 | 23/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 18/06/2024 | 08/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 26/05/2023 | 01/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 17/06/2022 | 25/07/2022 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20256 active · 3 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Luc Celis | Directorsince 03/04/2026 | ||
| Managing directorsince 15/02/2023Director27/10/2021 → 2021 accountsended | |||
Jan Christoph Gras | Directorsince 15/02/2023 | ||
| Director26/05/2023 → 28/01/2026 | |||
| Managing director15/02/2023 → 28/01/2026Director27/10/2021 → 2021 accountsended | |||
Philip Patrick Mertens | Director15/02/2023 → 28/01/2026 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Luc Selis | Director27/10/2021 → 2021 accounts | ||
Andy de Jong | Directoruntil 27/10/2021 | ||
Hermes Sanctorum-Vandevoorde | Directoruntil 27/10/2021 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates26/02/2026ONTSLAGEN - BENOEMINGEN
- Registered office10/02/2026MAATSCHAPPELIJKE ZETEL
- Mandates25/08/2025ONTSLAGEN - BENOEMINGEN
- Other27/06/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares29/04/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates09/10/2023ONTSLAGEN - BENOEMINGEN
- Mandates09/10/2023DEMISSIONS, NOMINATIONS
- Mandates12/04/2023KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Gaston Geenslaan 1, 3001 HeverleeCurrent | accounts 2025 | Accounts 2025 · 2026-00286243 |
| Meilrijk 98, 3290 Diest | accounts 2022 → 2024 | Accounts 2024 · 2025-00164810 |
| Meilrijk 96, 3290 Diest | accounts 2021 | Accounts 2021 · 2022-20225204 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PALEOCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00286243 |
Events
- 2025Annual accounts 2025-5,2 M €↓
- 2024Annual accounts 2024-3,8 M €↓
- 2023Annual accounts 2023-1,6 M €↓
- 2022Annual accounts 2022-664,7 k €↓
- 2021Annual accounts 2021-276,6 k €
- 26/10/2020IncorporationPrivate limited company